Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02089334 |
| Title | Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Rexahn Pharmaceuticals, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Rexahn Site | Tucson | Arizona | 85719 | United States | Details | |
| Rexahn Site | Duarte | California | 91010 | United States | Details | |
| Rexahn Site | Albuquerque | New Mexico | 87106 | United States | Details | |
| Rexahn Site | Bronx | New York | 10467 | United States | Details | |
| Rexahn Site | New York | New York | 10065 | United States | Details | |
| Rexahn Site | Salt Lake City | Utah | 84112 | United States | Details | |
| Rexahn Site | Seattle | Washington | 98101 | United States | Details |